🇺🇸 FDA

Company profile · Sponsor

Option

Option Therapeutics

OPTN · NYSE pharma CARSON CITY, NV, USA
Pipeline
1
Drugs
0
Patents
8

Quick answer

Option (OPTN) is a pharma company. headquartered in CARSON CITY, NV, USA. listed on NYSE. NovaPharmaNews links 1 pipeline program, 0 drugs, and 8 patents to this profile..

Company facts

Ticker OPTN
Exchange NYSE
Company type pharma
Headquarters CARSON CITY, NV, USA
SEC CIK 0002070577

Pipeline (1)

Search pipeline →

  1. Intravenous Immunoglobulin

    Option

    Autoimmune Epilepsy

    phase 3 small molecule terminated

    1 trial

Patents (8)

Search patents →

  1. US 11596610

    Compositions in support of health and mental accuity

    Expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10117937

    Highly branched alpha-D-glucans

    Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9289513

    Targeted cytokine for treatment of musculoskeletal diseases

    Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8685932

    Targeted transforming growth factor-beta-bound IgG for Treatment of Diseases

    Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 6770283

    DNA expression systems based on alphaviruses

    Expires Mon Jul 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  6. US 6692750

    Alphavirus expression vector

    Expires Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  7. US 6566093

    Alphavirus cDNA vectors

    Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6224879

    Alphavirus expression vector

    Expires Mon Apr 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is Option?

Option (OPTN) is a pharma company. headquartered in CARSON CITY, NV, USA. listed on NYSE. NovaPharmaNews links 1 pipeline program, 0 drugs, and 8 patents to this profile..

What pipeline programs does Option sponsor?

We track 1 ClinicalTrials.gov-linked program for Option, including Intravenous Immunoglobulin. Open each program for phase, modality, NCT IDs, and indication details.

Where does Option company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.